Attralus Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $25.2M
Latest Deal Amount
  • Investors
  • 3

Attralus General Information

Description

Developer of immunotherapies and an imaging diagnostic platform designed for multiple systemic amyloid disease treatment. The company specializes in the reserach and development of immunotherapies to clear amyloid fibrils in patients with systemic amyloid diseases, like a light chain(AL), transthyretin (ATTR) and LECT2 (ALECT2) amyloidosis, enabling the healthcare industry to treat amyloidosis patients in an efficient manner.

Contact Information

Formerly Known As
Aurora Bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 329 Oyster Point Boulevard
  • Third Floor
  • South San Francisco, CA 94080
  • United States
+1 (415) 000-0000

Attralus Timeline

2020
Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Attralus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Sep-2020 $25.2M 000.00 Completed Clinical Trials - General
1. Accelerator/Incubator 08-Nov-2019 Completed Clinical Trials - General
To view Attralus’s complete valuation and funding history, request access »

Attralus Executive Team (3)

Name Title Board Seat Contact Info
Spencer Guthrie Co-Founder, President, Chief Executive Officer & Board Member
Benson Fong Chief Financial Officer
Jonathan Wall Ph.D Co-Founder, Interim Chief Scientific Officer and Board Member
To view Attralus’s complete executive team members history, request access »

Attralus Board Members (5)

Name Representing Role Since
Corey Goodman Ph.D venBio Board Member 000 0000
Jonathan Wall Ph.D Attralus Co-Founder, Interim Chief Scientific Officer and Board Member 000 0000
Nancy Miller-Rich Attralus Board Member 000 0000
Richard Gaster Ph.D venBio Board Member 000 0000
Spencer Guthrie Attralus Co-Founder, President, Chief Executive Officer & Board Member 000 0000
To view Attralus’s complete board members history, request access »

Attralus Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Biobrit Venture Capital Minority 000 0000 000000 0
venBio Venture Capital Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
To view Attralus’s complete investors history, request access »